deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT03606122

5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities

Evaluation of the Suitability of a 5-ALA Patch (PD P 506 A, Alacare®) in the Photodynamic Therapy (PDT) of Actinic Keratosis on the Upper Extremities

Sponsor: photonamic GmbH & Co. KG

Interventions PD P 506 A
Updated 6 times since 2018 Last updated: Aug 27, 2019 Started: Jul 12, 2018 Primary completion: Jul 16, 2019 Completion: Jul 16, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03606122, this PHASE2 trial focuses on Actinic Keratoses and remains completed. Sponsored by photonamic GmbH & Co. KG, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2018 – ~Jan 2019 · 5 months · monthly snapshotNot Yet Recruiting~Jan 2019 – ~Sep 2019 · 8 months · monthly snapshotRecruiting~Sep 2019 – ~Jan 2021 · 16 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Sep 2019 — Jan 2021 [monthly]

    Completed PHASE2

    Status: RecruitingCompleted

  5. Jan 2019 — Sep 2019 [monthly]

    Recruiting PHASE2

    Status: Not Yet RecruitingRecruiting

Show 1 earlier version
  1. Aug 2018 — Jan 2019 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Jul 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • photonamic GmbH & Co. KG
Data source: photonamic GmbH & Co. KG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations